natco-launches-everolimus-in-usNATCOPHARM - 648 Change: -2.70 (-0.42 %)
News:Natco's marketing partner Breckenridge has launched the 10 mg strength of Everolimus tablets (generic for Afinitor) in the US market. According to industry sales data, market size for the 10 mg strength of Afinitor is ~ US$392 million during the 12 months ending July 2021
Views: Everolimus is a key launch for Natco in the US and is likely to bring some momentum in US sales. This comes before another key launch of Lenalidomide scheduled for Q4FY22 and together both launches are likely to drive US sales. We have considered these developments for our estimates.